Showing results (861-870 of 10,072) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 11, 2008
Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: potential therapeutical application of polyphenols to diet-related chronic diseasesT Magrone, M A Panaro, E Jirillo, et al.Current Pharmaceutical Design|November 11, 2008
Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivityJ L Guéant, R M Guéant-Rodriguez, I Aimone Gastin, et al.Current Pharmaceutical Design|November 11, 2008
Provocation tests in diagnosing drug hypersensitivityPhilippe-Jean Bousquet, Francesco Gaeta, Laure Bousquet-Rouanet, et al.Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.Current Pharmaceutical Design|November 11, 2008
Imaging of tumor hypoxia to predict treatment sensitivityH Minn, T J Grönroos, G Komar, et al.Current Pharmaceutical Design|November 11, 2008
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticalsH J K Ananias, I J de Jong, R A Dierckx, et al.Current Pharmaceutical Design|April 14, 2007
Activation of the innate immune system in atherosclerotic diseaseM M Oude Nijhuis, J K van Keulen, G Pasterkamp, et al.Current Pharmaceutical Design|April 14, 2007
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potentialJoanna M HillCurrent Pharmaceutical Design|April 14, 2007
Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and productionB A Murray, R J FitzGeraldCurrent Pharmaceutical Design|April 14, 2007
Nucleoprotein-derived and unbound ribonucleosides: bioactivity and potential applicationsDierk Martin, Hans MeiselPageof 1,008